Matches treatment options to a patient's disease profile using proteomics.
Consented intake · your records travel with you · nothing moves without your sign-off
mProbe uses proteomics to support biomarker-drug matching: recommending the treatment options most likely to produce an effective response based on a patient's disease profile from test data. The aim is to identify the best treatment ideas using the best global thinking and to predict treatment response. It is for patients weighing which therapy fits their disease.
Prefer the source? mProbe* (proteomics)'s own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how mProbe* (proteomics) handles billing.
We don't have confirmed insurance details for mProbe* (proteomics) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in mProbe*'s details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Identify the best treatment ideas using the best global thinking, predict best treatment response
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.